(Q40886850)

24 September 2017

1 reference

title

Comparative pharmacokinetics of antiviral nucleoside analogues (English)

1 reference

24 September 2017

1 reference

G D Morse

1

1 reference

24 September 2017

M J Shelton

series ordinal

2

1 reference

24 September 2017

A M O'Donnell

series ordinal

3

1 reference

24 September 2017

1 February 1993

1 reference

Clinical Pharmacokinetics

24 September 2017

1 reference

24 September 2017

24

1 reference

24 September 2017

2

1 reference

24 September 2017

101-123

1 reference

https://scigraph.springernature.com/pub.10.2165/00003088-199324020-00002

24 September 2017

0 references

cites work

Hypoxanthine-arabinoside pharmacokinetics after adenine arabinoside administration to a patient with renal failure

1 reference

12 December 2020

Overview of acyclovir pharmacokinetic disposition in adults and children.

1 reference

12 December 2020

Clinical pharmacology of 2',3'-dideoxyinosine in human immunodeficiency virus-infected children.

1 reference

12 December 2020

Didanosine pharmacokinetics in patients with normal and impaired renal function: influence of hemodialysis

1 reference

12 December 2020

Vidarabine: a preliminary review of its pharmacological properties and therapeutic use.

1 reference

12 December 2020

Pharmacokinetics of didanosine in patients with acquired immunodeficiency syndrome or acquired immunodeficiency syndrome-related complex.

1 reference

12 December 2020

Pharmacokinetics of acyclovir after intravenous and oral administration.

1 reference

12 December 2020

Pharmacokinetics and bioavailability of zidovudine in humans

1 reference

12 December 2020

Initial studies on the cellular pharmacology of 2',3'-dideoxyinosine, an inhibitor of HIV infectivity

1 reference

12 December 2020

Acyclovir. An updated review of its antiviral activity, pharmacokinetic properties and therapeutic efficacy

1 reference

12 December 2020

Human pharmacokinetics of the antiviral drug DHPG.

1 reference

12 December 2020

Pharmacokinetics of ganciclovir in a patient undergoing hemodialysis

1 reference

12 December 2020

Decreased and variable systemic availability of zidovudine in patients with AIDS if administered with a meal.

1 reference

12 December 2020

Acyclovir: Mechanism of Action, Pharmacokinetics, Safety and Clinical Applications

1 reference

12 December 2020

Pharmacokinetics of 2',3'-dideoxycytidine in patients with AIDS and related disorders.

1 reference

12 December 2020

Metabolic activation of the nucleoside analog 9-[( 2-hydroxy-1-(hydroxymethyl)ethoxy]methyl)guanine in human diploid fibroblasts infected with human cytomegalovirus

1 reference

12 December 2020

Intraperitoneal administration of acyclovir in patients receiving continuous ambulatory peritoneal dialysis

1 reference

12 December 2020

Human pharmacokinetics and tolerance of oral ganciclovir

1 reference

12 December 2020

Simultaneous quantification of zidovudine and its glucuronide in serum by high-performance liquid chromatography

1 reference

12 December 2020

Ganciclovir pharmacokinetics during renal impairment

1 reference

12 December 2020

Effect of renal failure on the pharmacokinetics of acyclovir.

1 reference

12 December 2020

Bioequivalence assessment of zidovudine (Retrovir) syrup, solution, and capsule formulations in patients infected with human immunodeficiency virus

1 reference

12 December 2020

Zidovudine in asymptomatic human immunodeficiency virus infection. A controlled trial in persons with fewer than 500 CD4-positive cells per cubic millimeter. The AIDS Clinical Trials Group of the National Institute of Allergy and Infectious Diseases

1 reference

12 December 2020

Overview of the preclinical development of an antiretroviral drug, 2',3'-dideoxyinosine

1 reference

12 December 2020

Population pharmacokinetics of zidovudine. The Veterans Administration Cooperative Studies Group

1 reference

12 December 2020

Pharmacokinetic-interaction study of didanosine and ranitidine in patients seropositive for human immunodeficiency virus

1 reference

12 December 2020

Modulation of 9-beta-D-arabinofuranosyladenine 5'-triphosphate and deoxyadenosine triphosphate in leukemic cells by 2'-deoxycoformycin during therapy with 9-beta-D-arabinofuranosyladenine

1 reference

12 December 2020

Drug-resistant strains of AIDS virus found

1 reference

12 December 2020

Pharmacokinetics of ribavirin and urinary excretion of the major metabolite 1,2,4-triazole-3-carboxamide in normal volunteers.

1 reference

12 December 2020

The safety and efficacy of zidovudine (AZT) in the treatment of subjects with mildly symptomatic human immunodeficiency virus type 1 (HIV) infection. A double-blind, placebo-controlled trial. The AIDS Clinical Trials Group

1 reference

12 December 2020

Acyclovir pharmacokinetics in a patient on continuous ambulatory peritoneal dialysis

1 reference

12 December 2020

Management of cytomegalovirus disease with antiviral drugs

1 reference

12 December 2020

In vivo activity against HIV and favorable toxicity profile of 2',3'-dideoxyinosine

1 reference

12 December 2020

Ribavirin pharmacokinetics

1 reference

12 December 2020

Acetaminophen does not impair clearance of zidovudine

1 reference

12 December 2020

Pharmacokinetic disposition of zidovudine during pregnancy

1 reference

12 December 2020

Pharmacokinetic interactions of zidovudine and methadone in intravenous drug-using patients with HIV infection

1 reference

12 December 2020

Treatment of cytomegalovirus pneumonia with high-dose acyclovir

1 reference

12 December 2020

Plasma levels and urinary excretion of vidarabine after repeated dosing

1 reference

12 December 2020

Clinical pharmacokinetics of zidovudine. An overview of current data

1 reference

12 December 2020

Zidovudine. A review of its pharmacodynamic and pharmacokinetic properties, and therapeutic efficacy

1 reference

12 December 2020

State-of-the-art of zidovudine monitoring

1 reference

12 December 2020

Alteration of zidovudine pharmacokinetics by probenecid in patients with AIDS or AIDS-related complex

1 reference

12 December 2020

Fluorescence polarization immunoassay for zidovudine

1 reference

12 December 2020

A controlled trial comparing continued zidovudine with didanosine in human immunodeficiency virus infection. The NIAID AIDS Clinical Trials Group

1 reference

12 December 2020

Multiple dose pharmacokinetics of intravenous acyclovir in patients on continuous ambulatory peritoneal dialysis

1 reference

12 December 2020

Intracellular zidovudine (ZDV) and ZDV phosphates as measured by a validated combined high-pressure liquid chromatography-radioimmunoassay procedure

1 reference

12 December 2020

Genetic analysis of 2',3'-dideoxycytidine incorporation into cultured human T lymphoblasts

1 reference

12 December 2020

Pharmacokinetics of acyclovir suspension in infants and children

1 reference

12 December 2020

Pharmacokinetics of 2',3'-dideoxyinosine in patients with severe human immunodeficiency infection. II. The effects of different oral formulations and the presence of other medications.

1 reference

12 December 2020

Inhibition of herpes simplex virus-induced DNA polymerase activity and viral DNA replication by 9-(2-hydroxyethoxymethyl)guanine and its triphosphate

1 reference

12 December 2020

Hemodialysis clearance of intravenously administered ribavirin

1 reference

12 December 2020

Pharmacokinetics of 2',3'-dideoxyadenosine and 2',3'-dideoxyinosine in patients with severe human immunodeficiency virus infection

1 reference

12 December 2020

Clinical pharmacokinetics of ganciclovir in patients with normal and impaired renal function

1 reference

12 December 2020

Ribavirin antagonizes inhibitory effects of pyrimidine 2',3'-dideoxynucleosides but enhances inhibitory effects of purine 2',3'-dideoxynucleosides on replication of human immunodeficiency virus in vitro

1 reference

12 December 2020

Antiviral treatment of chronic hepatitis B virus infection: pharmacokinetics and side effects of interferon and adenine arabinoside alone and in combination

1 reference

12 December 2020

Plasma and cerebrospinal fluid pharmacokinetics of 3'-azido-3'-deoxythymidine: a novel pyrimidine analog with potential application for the treatment of patients with AIDS and related diseases

1 reference

12 December 2020

Zidovudine update: 1990.

1 reference

12 December 2020

Phosphorylation of 3'-azido-3'-deoxythymidine and selective interaction of the 5'-triphosphate with human immunodeficiency virus reverse transcriptase

1 reference

12 December 2020

Zidovudine disposition in patients with severe renal impairment: influence of hemodialysis

1 reference

12 December 2020

Phosphorylation of acyclovir (acycloguanosine) monophosphate by GMP kinase

1 reference

12 December 2020

Pharmacokinetics of oral zidovudine (azidothymidine) in patients with AIDS when administered with and without a high-fat meal

1 reference

12 December 2020

Metabolism of arabinosyladenine in herpes simplex virus-infected and uninfected cells. Correlation with inhibition of DNA synthesis and role in antiviral selectivity

1 reference

12 December 2020

Meningeal diffusion of high doses of acyclovir given with probenecid

1 reference

12 December 2020

Pharmacokinetics and long-term tolerance to ribavirin in asymptomatic patients infected with human immunodeficiency virus

1 reference

12 December 2020

Pharmacokinetics of orally administered zidovudine among patients with hemophilia and asymptomatic human immunodeficiency virus (HIV) infection

1 reference

12 December 2020

Effect of liver disease on pharmacokinetics and toxicity of 9-beta-D-arabinofuranosyladenine-5-phosphate

1 reference

12 December 2020

Ribavirin disposition in high-risk patients for acquired immunodeficiency syndrome.

1 reference

12 December 2020

Fetoplacental passage of 2',3'-dideoxyinosine

1 reference

12 December 2020

Human gastrointestinal absorption of acyclovir from tablet duodenal infusion and sipped solution

1 reference

12 December 2020

Dideoxycytidine permeation and salvage by mouse leukemia cells and human erythrocytes

1 reference

12 December 2020

Human pharmacokinetics of acyclovir (an antiviral agent) following rapid intravenous injection

1 reference

12 December 2020

Pharmacokinetics of vidarabine in the treatment of infants and children with infections due to herpesviruses

1 reference

12 December 2020

Antiviral activity and mechanism of action of ganciclovir

1 reference

12 December 2020

Evaluation of saliva as a specimen for monitoring zidovudine therapy in HIV-infected patients

1 reference

12 December 2020

Pharmacokinetics of zidovudine in a patient on maintenance hemodialysis

1 reference

12 December 2020

Acyclovir in human breast milk

1 reference

12 December 2020

Concurrent zidovudine levels in semen and serum determined by radioimmunoassay in patients with AIDS or AIDS-related complex

1 reference

12 December 2020

The disposition and metabolism of 2',3'-dideoxycytidine, an in vitro inhibitor of human T-lymphotrophic virus type III infectivity, in mice and monkeys

1 reference

12 December 2020

Food-induced reduction in bioavailability of didanosine.

1 reference

12 December 2020

In vitro measurement of phosphorylated zidovudine in peripheral blood leucocytes

1 reference

12 December 2020

Dideoxycytidine alone and in an alternating schedule with zidovudine in children with symptomatic human immunodeficiency virus infection

1 reference

12 December 2020

Activity of 9-[2-hydroxy-1-(hydroxymethyl)ethoxymethyl]guanine in the treatment of cytomegalovirus pneumonia

1 reference

12 December 2020

Intravenous and oral zidovudine pharmacokinetics and coagulation effects in asymptomatic human immunodeficiency virus-infected hemophilia patients

1 reference

12 December 2020

Phase I studies of 2',3'-dideoxycytidine in severe human immunodeficiency virus infection as a single agent and alternating with zidovudine (AZT).

1 reference

12 December 2020

Probenecid and zidovudine metabolism

1 reference

12 December 2020

HIV with reduced sensitivity to zidovudine (AZT) isolated during prolonged therapy

1 reference

12 December 2020

Acyclovir concentrations in serum and cerebrospinal fluid at steady state

1 reference

12 December 2020

Dideoxyinosine in Children with Symptomatic Human Immunodeficiency Virus Infection

1 reference

12 December 2020

Drugs five years later: acyclovir

1 reference

12 December 2020

The role of cytoplasmic deoxycytidine kinase in the mitochondrial effects of the anti-human immunodeficiency virus compound, 2‘,3‘-dideoxycytidine

1 reference

12 December 2020

Inhibition of purified human and herpes simplex virus-induced DNA polymerases by 9-(2-hydroxyethoxymethyl)guanine triphosphate. Effects on primer-template function

1 reference

12 December 2020

Pharmacodynamics of 2′,3′-dideoxycytidine: An inhibitor of human immunodeficiency virus

1 reference

12 December 2020

Herpes simplex encephalitis: vidarabine therapy and diagnostic problems

1 reference

12 December 2020

Once-daily administration of 2',3'-dideoxyinosine (ddI) in patients with the acquired immunodeficiency syndrome or AIDS-related complex. Results of a Phase I trial

1 reference

12 December 2020

Metabolic pathways for the activation of the antiretroviral agent 2',3'-dideoxyadenosine in human lymphoid cells

1 reference

12 December 2020

2',3'-dideoxyinosine (ddI) in patients with the acquired immunodeficiency syndrome or AIDS-related complex. A phase I trial

1 reference

12 December 2020

Pharmacokinetics of zidovudine administered intravenously and orally in children with human immunodeficiency virus infection.

1 reference

12 December 2020

The pharmacokinetics of zidovudine administered by continuous infusion in children

1 reference

12 December 2020

Inhibition by acyclovir of cell growth and DNA synthesis of cells biochemically transformed with Herpesvirus genetic information

1 reference

12 December 2020

Studies of 9-beta-D-arabinofuranosyladenine in man

1 reference

12 December 2020

Adenine arabinoside and allopurinol--possible adverse drug interaction

1 reference

12 December 2020

The efficacy of azidothymidine (AZT) in the treatment of patients with AIDS and AIDS-related complex. A double-blind, placebo-controlled trial

1 reference

12 December 2020

Delayed cytotoxicity and selective loss of mitochondrial DNA in cells treated with the anti-human immunodeficiency virus compound 2',3'-dideoxycytidine

1 reference

12 December 2020

Phosphorylation of the antiviral precursor 9-(1,3-dihydroxy-2-propoxymethyl)guanine monophosphate by guanylate kinase isozymes

1 reference

12 December 2020

Cellular metabolism of 2',3'-dideoxycytidine, a compound active against human immunodeficiency virus in vitro

1 reference

12 December 2020

Detection of AIDS virus in macrophages in brain tissue from AIDS patients with encephalopathy

1 reference

12 December 2020

Disposition of intravenous radioactive acyclovir

1 reference

12 December 2020

Pancreatitis and pancreatic dysfunction in patients taking dideoxyinosine

1 reference

12 December 2020

A pilot study of the bioavailability and pharmacokinetics of 2',3'-dideoxycytidine in patients with AIDS or AIDS-related complex

1 reference

12 December 2020

Comparative pharmacokinetics of zidovudine (AZT) and its metabolite (G.AZT) in healthy subjects and HIV seropositive patients

1 reference

12 December 2020

Activity of 9-(1,3-dihydroxy-2-propoxymethyl)guanine compared with that of acyclovir against human, monkey, and rodent cytomegaloviruses

1 reference

12 December 2020

The effect of acetaminophen on zidovudine metabolism in HIV-infected patients

1 reference

12 December 2020

Inhibition of herpes simplex virus transformed and nontransformed cells by acycloguanosine: Mechanisms of uptake and toxicity

1 reference

12 December 2020

Ribavirin enters cerebrospinal fluid.

1 reference

12 December 2020

Initial studies on the cellular pharmacology of 2',3-dideoxycytidine, an inhibitor of HTLV-III infectivity.

1 reference

12 December 2020

Impact of bioavailability on determination of the maximal tolerated dose of 2',3'-dideoxyinosine in phase I trials

1 reference

12 December 2020

Pharmacology, Tolerance, and Antiviral Activity of Vidarabine Monophosphate in Humans

1 reference

12 December 2020

Multiple-dose pharmacokinetics of oral zidovudine in hemophilia patients with human immunodeficiency virus infection

1 reference

12 December 2020

2',3'-Dideoxycytidine: regulation of its metabolism and anti-retroviral potency by natural pyrimidine nucleosides and by inhibitors of pyrimidine nucleotide synthesis

1 reference

12 December 2020

Influence of hemodialysis on acyclovir pharmacokinetics in patients with chronic renal failure

1 reference

12 December 2020

Unexpected accumulation of acyclovir in breast milk with estimation of infant exposure

1 reference

12 December 2020

Fetoplacental passage of zidovudine

1 reference

12 December 2020

Effects of probenecid on the pharmacokinetics and elimination of acyclovir in humans

1 reference

12 December 2020

Growth Inhibition by Acycloguanosine of Herpesviruses Isolated from Human Infections

1 reference

12 December 2020

Strategies for antiviral therapy in AIDS.

1 reference

12 December 2020

Initial studies on the cellular pharmacology of 2',3'-dideoxyadenosine, an inhibitor of HTLV-III infectivity

1 reference

12 December 2020

Acyclovir malabsorption.

1 reference

12 December 2020

A review of the pharmacokinetics of zidovudine in man.

1 reference

12 December 2020

3'-Azido-3'-deoxythymidine (BW A509U): an antiviral agent that inhibits the infectivity and cytopathic effect of human T-lymphotropic virus type III/lymphadenopathy-associated virus in vitro

1 reference

12 December 2020

The metabolism of ribavirin in erythrocytes and nucleated cells

1 reference

12 December 2020

Ribavirin pharmacodynamics in high-risk patients for acquired immunodeficiency syndrome.

1 reference

12 December 2020

Pharmacokinetics of acyclovir in the term human pregnancy and neonate

1 reference

12 December 2020

Phosphorylation of 2',3'-dideoxyinosine by cytosolic 5'-nucleotidase of human lymphoid cells

1 reference

12 December 2020

Enzymatic phosphorylation of acyclic nucleoside analogs and correlations with antiherpetic activities

1 reference

12 December 2020

Circulating p24 antigen levels and responses to dideoxycytidine in human immunodeficiency virus (HIV) infections. A phase I and II study

1 reference

12 December 2020

10.2165/00003088-199324020-00002

Identifiers

DOI

1 reference

Dimensions Publication ID

24 September 2017

0 references

1 reference